| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_0a969ab9e8e0de13f4fa93a1560921f6 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2077
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2054
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-5575
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-69
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2013
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-6951 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-69
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-5575
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-20 |
| filingDate |
2021-05-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_33c02615f4249865e15ef0b56e6a504f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_47038a272a8c0b435d014d467911af5c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b6d983f64d4e175f525ff7a6b8892204 |
| publicationDate |
2021-12-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-2021241941-A1 |
| titleOfInvention |
Limaprost-containing sustained release formulation |
| abstract |
The present invention provides a sustained release formulation containing: at least one selected from the group consisting of limaprost and limaprost alfadex as an active ingredient; ethylcellulose as a sustained-release agent; hydroxypropyl betadex as a first stabilizer; and glyceryl behenate as a second stabilizer. A limaprost-containing sustained release formulation according to the present invention not only exhibits a sustained therapeutic effect by appropriately maintaining the drug concentration of limaprost even when administered twice a day, but can also increase the stability of limaprost. |
| priorityDate |
2020-05-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |